Search research articles
Contact Us
Filters
Showing results (161-170 of 304) with videos related to
Page
of 31
Sort By:
Journal of the National Cancer Institute
|
August 23, 2015
Evaluating Continuous Tumor Measurement-Based Metrics as Phase II Endpoints for Predicting Overall Survival
Ming-Wen An, Xinxin Dong, Jeffrey Meyers, et al.
Therapeutic Advances in Medical Oncology
|
July 7, 2018
5-fluorouracil and cardiotoxicity: a review
Jaskanwal D Sara, Jasvinder Kaur, Ryan Khodadadi, et al.
Cancer Treatment Reviews
|
July 30, 2015
Extended RAS analysis for anti-epidermal growth factor therapy in patients with metastatic colorectal cancer
J Randolph Hecht, Jean-Yves Douillard, Lee Schwartzberg, et al.
The Oncologist
|
March 2, 2021
Use of Molecular Assays and Circulating Tumor DNA in Early-Stage Colorectal Cancer: A Roundtable Discussion of the Gastrointestinal Cancer Therapy Expert Group
Arturo Loaiza-Bonilla, Al B Benson, Axel Grothey, et al.
Clinical Colorectal Cancer
|
November 7, 2018
Bolus 5-fluorouracil (5-FU) In Combination With Oxaliplatin Is Safe and Well Tolerated in Patients Who Experienced Coronary Vasospasm With Infusional 5-FU or Capecitabine
Sakti Chakrabarti, Jaskanwal Sara, Ronstan Lobo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 21, 2007
End points in advanced colon cancer clinical trials: a review and proposal
Carmen Allegra, Charles Blanke, Marc Buyse, et al.
SOJ Anesthesiology & Pain Management
|
November 4, 2015
Comparing and Validating Simple Measures of Patient-Reported Peripheral Neuropathy for Oncology Clinical Trials: NCCTG N0897 (Alliance) A Pooled Analysis of 2440 Patients
Heshan Liu, Angelina D Tan, Rui Qin, et al.
Frontiers in Oncology
|
March 7, 2019
Impact of Tumor Location and Variables Associated With Overall Survival in Patients With Colorectal Cancer: A Mayo Clinic Colon and Rectal Cancer Registry Study
Cassia B Wang, Faisal Shahjehan, Amit Merchea, et al.
The Oncologist
|
September 15, 2017
Impact of Metastasectomy in the Multimodality Approach for <i>BRAF</i> V600E Metastatic Colorectal Cancer: The Mayo Clinic Experience
Benny Johnson, Zhaohui Jin, Mark J Truty, et al.
BMC Cancer
|
July 15, 2016
Chemotherapy induced neutropenia at 1-month mark is a predictor of overall survival in patients receiving TAS-102 for refractory metastatic colorectal cancer: a cohort study
Pashtoon M Kasi, Daisuke Kotani, Michael Cecchini, et al.
Page
of 31
Search research articles
Search
Showing results (161-170 of 304) with videos related to
Sort By:
Page
of 31
Journal of the National Cancer Institute
|
August 23, 2015
Evaluating Continuous Tumor Measurement-Based Metrics as Phase II Endpoints for Predicting Overall Survival
Ming-Wen An, Xinxin Dong, Jeffrey Meyers, et al.
Therapeutic Advances in Medical Oncology
|
July 7, 2018
5-fluorouracil and cardiotoxicity: a review
Jaskanwal D Sara, Jasvinder Kaur, Ryan Khodadadi, et al.
Cancer Treatment Reviews
|
July 30, 2015
Extended RAS analysis for anti-epidermal growth factor therapy in patients with metastatic colorectal cancer
J Randolph Hecht, Jean-Yves Douillard, Lee Schwartzberg, et al.
The Oncologist
|
March 2, 2021
Use of Molecular Assays and Circulating Tumor DNA in Early-Stage Colorectal Cancer: A Roundtable Discussion of the Gastrointestinal Cancer Therapy Expert Group
Arturo Loaiza-Bonilla, Al B Benson, Axel Grothey, et al.
Clinical Colorectal Cancer
|
November 7, 2018
Bolus 5-fluorouracil (5-FU) In Combination With Oxaliplatin Is Safe and Well Tolerated in Patients Who Experienced Coronary Vasospasm With Infusional 5-FU or Capecitabine
Sakti Chakrabarti, Jaskanwal Sara, Ronstan Lobo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 21, 2007
End points in advanced colon cancer clinical trials: a review and proposal
Carmen Allegra, Charles Blanke, Marc Buyse, et al.
SOJ Anesthesiology & Pain Management
|
November 4, 2015
Comparing and Validating Simple Measures of Patient-Reported Peripheral Neuropathy for Oncology Clinical Trials: NCCTG N0897 (Alliance) A Pooled Analysis of 2440 Patients
Heshan Liu, Angelina D Tan, Rui Qin, et al.
Frontiers in Oncology
|
March 7, 2019
Impact of Tumor Location and Variables Associated With Overall Survival in Patients With Colorectal Cancer: A Mayo Clinic Colon and Rectal Cancer Registry Study
Cassia B Wang, Faisal Shahjehan, Amit Merchea, et al.
The Oncologist
|
September 15, 2017
Impact of Metastasectomy in the Multimodality Approach for <i>BRAF</i> V600E Metastatic Colorectal Cancer: The Mayo Clinic Experience
Benny Johnson, Zhaohui Jin, Mark J Truty, et al.
BMC Cancer
|
July 15, 2016
Chemotherapy induced neutropenia at 1-month mark is a predictor of overall survival in patients receiving TAS-102 for refractory metastatic colorectal cancer: a cohort study
Pashtoon M Kasi, Daisuke Kotani, Michael Cecchini, et al.
Page
of 31